Sanuwave Health Reports Preliminary Q1 2026 Revenue of $9.6–$9.7 Million, Up 3-4% Year-over-Year
Sanuwave Health, a provider of FDA-approved directed energy systems for advanced wound care, announced preliminary Q1 2026 revenues of $9.6–$9.7 million, representing a 3-4% increase year-over-year and aligning with prior guidance. Despite some delays in deal closures and changes in reimbursement policies impacting the wound care market, strong pra…